| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Fibrogen Inc (KYNB) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. KYNB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 60.0K | $412.8K | - | |
| CFO | 26.0K | $178.9K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - | |
| Dir | 7.0K | $48.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 19, 2020 | Kearns Thomas F Jr | Director | Sale+OE | 18,000 | $23.17 | $417,074.40 | -11.1% | |
| Mar 19, 2020 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $25.52 | $287,081.25 | -1.1% | |
| Mar 16, 2020 | Cotroneo Pat | SVP, Finance And CFO | Sell | 9,239 | $26.36 | $243,540.04 | -3.8% | |
| Feb 12, 2020 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $45.23 | $508,816.50 | -2.7% | |
| Feb 10, 2020 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $42.69 | $256,140.00 | -17.4% | |
| Jan 7, 2020 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $42.87 | $482,287.50 | -4.1% | |
| Jan 6, 2020 | Kurkijarvi Kalevi | Director | Sale+OE | 6,000 | $42.66 | $255,960.00 | -17.4% | |
| Dec 20, 2019 | Cotroneo Pat | SVP, Finance And CFO | Sale+OE | 59,456 | $45.67 | $2,715,516.60 | -10.4% | |
| Dec 17, 2019 | Chung Christine88 | SVP, China Operations | Sale+OE | 11,250 | $47.03 | $529,075.78 | -2.1% | |
| Dec 16, 2019 | Yu K Peony | Chief Medical Officer | Sell | 3,420 | $46.68 | $159,645.60 | -1.9% |